Name: | Description: | Size: | Format: | |
---|---|---|---|---|
157.74 KB | Adobe PDF |
Advisor(s)
Abstract(s)
The high effectiveness of phosphodiesterase type 5 inhibitors (PDE5-i) in the treatment of erectile dysfunction (ED) has been demonstrated. However, previous research shows that PDE5-i treatments have high discontinuation rates.
Description
Keywords
Erectile dysfunction PDE5 Inhibitors Adherence ED Causes PDE5 Inhibitors Adherence ED Causes
Citation
Sexual Medicine, 2(2), 96-102
Publisher
Elsevier Inc.